| Defining dysfunction: Natural selection, design, and drawing a line PH Schwartz Philosophy of Science 74 (3), 364-385, 2007 | 157 | 2007 |
| ERCC1 Genotype and Phenotype in Epithelial Ovarian Cancer Identify Patients Likely to Benefit From Paclitaxel Treatment in Addition to Platinum-Based Therapy S Smith, D Su, IA Rigault de la Longrais, P Schwartz, M Puopolo, ... Journal of clinical oncology 25 (33), 5172-5179, 2007 | 131 | 2007 |
| Randomized, open-label, phase III study comparing patupilone (EPO906) with pegylated liposomal doxorubicin in platinum-refractory or-resistant patients with recurrent … N Colombo, E Kutarska, M Dimopoulos, DS Bae, I Rzepka-Gorska, ... J Clin Oncol 30 (31), 3841-3847, 2012 | 127 | 2012 |
| Older adults and forgoing cancer screening:“I think it would be strange” AM Torke, PH Schwartz, LR Holtz, K Montz, GA Sachs JAMA internal medicine 173 (7), 526-531, 2013 | 117 | 2013 |
| Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxel D Su, SM Smith, M Preti, P Schwartz, TJ Rutherford, G Menato, S Danese, ... Cancer 115 (11), 2453-2463, 2009 | 104 | 2009 |
| MicroRNA let-7a: a potential marker for selection of paclitaxel in ovarian cancer management L Lu, P Schwartz, L Scarampi, T Rutherford, EM Canuto, H Yu, D Katsaros Gynecologic oncology 122 (2), 366-371, 2011 | 99 | 2011 |
| Decision and discovery in defining ‘disease’ PH Schwartz Establishing medical reality: Essays in the metaphysics and epistemology of …, 2007 | 79 | 2007 |
| Patient preferences in controlling access to their electronic health records: a prospective cohort study in primary care PH Schwartz, K Caine, SA Alpert, EM Meslin, AE Carroll, WM Tierney Journal of general internal medicine 30, 25-30, 2015 | 69 | 2015 |
| Risk and disease PH Schwartz Perspectives in biology and medicine 51 (3), 320-334, 2008 | 58 | 2008 |
| Reframing the disease debate and defending the biostatistical theory PH Schwartz Journal of Medicine and Philosophy 39 (6), 572-589, 2014 | 56 | 2014 |
| Pre-imaginal experience and nestmate brood recognition in the carpenter ant, Camponotus floridanus NF Carlin, PH Schwartz Animal Behaviour 38 (1), 89-95, 1989 | 56 | 1989 |
| Designing a system for patients controlling providers’ access to their electronic health records: organizational and technical challenges JC Leventhal, JA Cummins, PH Schwartz, DK Martin, WM Tierney Journal of general internal medicine 30, 17-24, 2015 | 55 | 2015 |
| Questioning the quantitative imperative: decision aids, prevention, and the ethics of disclosure PH Schwartz Hastings Center Report 41 (2), 30-39, 2011 | 52 | 2011 |
| Provider responses to patients controlling access to their electronic health records: a prospective cohort study in primary care WM Tierney, SA Alpert, A Byrket, K Caine, JC Leventhal, EM Meslin, ... Journal of general internal medicine 30, 31-37, 2015 | 48 | 2015 |
| The ethics of information: absolute risk reduction and patient understanding of screening PH Schwartz, EM Meslin Journal of general internal medicine 23, 867-870, 2008 | 47 | 2008 |
| Giving patients granular control of personal health information: using an ethics ‘Points to Consider’to inform informatics system designers EM Meslin, SA Alpert, AE Carroll, JD Odell, WM Tierney, PH Schwartz International journal of medical informatics 82 (12), 1136-1143, 2013 | 46 | 2013 |
| Defending the distinction between treatment and enhancement PH Schwartz The American Journal of Bioethics 5 (3), 17-19, 2005 | 46 | 2005 |
| Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer L Lu, D Katsaros, A Wiley, IAR de la Longrais, M Puopolo, P Schwartz, ... Gynecologic oncology 103 (3), 990-995, 2006 | 44 | 2006 |
| Proper function and recent selection PH Schwartz Philosophy of Science 66 (S3), S210-S222, 1999 | 43 | 1999 |
| The continuing usefulness account of proper function PH Schwartz | 34 | 2002 |
